atipamezole has been researched along with Nerve Degeneration in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Halonen, T; Kotti, T; Miettinen, R; Riekkinen, PJ; Toppinen, A; Tuunanen, J | 1 |
1 other study(ies) available for atipamezole and Nerve Degeneration
Article | Year |
---|---|
Alpha 2-adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Anticonvulsants; Disease Models, Animal; gamma-Aminobutyric Acid; Hippocampus; Histocytochemistry; Imidazoles; Kainic Acid; Male; Medetomidine; Nerve Degeneration; Neurons; Rats; Rats, Wistar; Seizures; Status Epilepticus; Vigabatrin | 1995 |